Recent review of COVID-19 management: Diagnosis, treatment and vaccination

VP Chavda, S Vuppu, T Mishra, S Kamaraj… - Pharmacological …, 2022 - Springer
The idiopathic Coronavirus disease 2019 (COVID-19) pandemic outbreak caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global …

mRNA-based vaccines and therapeutics for COVID-19 and future pandemics

VP Chavda, S Soni, LK Vora, S Soni, A Khadela… - Vaccines, 2022 - mdpi.com
An unheard mobilization of resources to find SARS-CoV-2 vaccines and therapies has been
sparked by the COVID-19 pandemic. Two years ago, COVID-19's launch propelled mRNA …

Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world

VP Chavda, Q Yao, LK Vora, V Apostolopoulos… - Frontiers in …, 2022 - frontiersin.org
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …

Adenoviral vector-based vaccine platform for COVID-19: Current status

VP Chavda, R Bezbaruah, D Valu, B Patel, A Kumar… - Vaccines, 2023 - mdpi.com
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the
21st century, claiming millions of lives and putting a huge burden on the global economy …

Therapeutic monoclonal antibodies for COVID-19 management: an update

VP Chavda, R Prajapati, D Lathigara… - Expert opinion on …, 2022 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
affected more than 529 million people, and today the world is facing different mutant strains …

COVID-19 and vaccination: myths vs science

VP Chavda, Y Chen, J Dave, ZS Chen… - Expert Review of …, 2022 - Taylor & Francis
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …

mRNA-based vaccine for COVID-19: they are new but not unknown!

VP Chavda, G Jogi, S Dave, BM Patel, L Vineela Nalla… - Vaccines, 2023 - mdpi.com
mRNA vaccines take advantage of the mechanism that our cells use to produce proteins.
Our cells produce proteins based on the knowledge contained in our DNA; each gene …

Conventional and novel diagnostic tools for the diagnosis of emerging SARS-CoV-2 variants

VP Chavda, DD Valu, PK Parikh, N Tiwari, AS Chhipa… - Vaccines, 2023 - mdpi.com
Accurate identification at an early stage of infection is critical for effective care of any
infectious disease. The “coronavirus disease 2019 (COVID-19)” outbreak, caused by the …

Therapeutics to tackle Omicron outbreak

VP Chavda, EN Hanuma Kumar Ghali… - …, 2022 - Taylor & Francis
Full article: Therapeutics to Tackle Omicron Outbreak Skip to Main Content Taylor and Francis
Online homepage Taylor and Francis Online homepage Log in | Register Cart 1.Home 2.All …

Pseudoscience and fraudulent products for COVID-19 management

VP Chavda, SS Sonak, NK Munshi… - … Science and Pollution …, 2022 - Springer
As of now, the COVID-19 pandemic has become uncontrolled and is spreading widely
throughout the world. Additionally, new variants of the mutated viral variants have been …